ACE2 and COVID-19: Although other hepatic cell types like cholangiocytes showed higher expression of ACE2 than hepatocytes, no direct evidence of infection in these cells have been reported in the liver of patients with COVID-1959 in spite of the fact that viral particles compatible with SARS-CoV-2 were identified by electron microscopy techniques in the hepatocytes from COVID-19 autopsies1.